BOPA Introduction to Oncology Course held at the Christie

So today we ran the second of two BOPA Introduction to Oncology Courses. This one was at the Christie Hospital.

We would like to thank all our speakers. We are  pleased to have some new people speak as part of BOPA E&T. The new faces speaking for BOPA for the first time; we had Lynne Thompson presenting on pharmaceutical care planning with an in-depth case study for a DLBCL patient. Secondly we had Rhona Johnson: Christie’s very own SACT practice facilitator teaching delegates about the management of the complications of administering chemotherapy.

Thank you very much to all for coming, we hope you enjoyed the day. Watch this space for more events from BOPA E&T.

Best wishes
BOPA E&T Team

Latest News

By Pharmaceutical Press (PhP) on 15th June 2026

Exciting new project with the Pharmaceutical Press (PhP)

Expressions of interest: We are currently seeking expressions of interest to support an exciting new project with the Pharmaceutical Press (PhP). PhP is developing a new resource to support healthcare…

Read article
By BOPA Research Subcommittee on 15th June 2026

Deadline EXTENDED: Abstract Submission for #BOPA2026

Abstract Submission for the 29th Annual BOPA Conference 2026 is now OPEN   Deadline for Abstract Submission for the 29th Annual BOPA Conference 2026 has been EXTENDED! Don’t miss the…

Read article
By BOPA on 15th June 2026

The BOPA Training and Development Grant – BOPA Conference 2026

BOPA are offering (in collaboration with Gilead) 16 funded places to the BOPA 2026 Conference in London from 2-4th Oct 20265. Information can be found here – The BOPA Training and Development Grant…

Read article
By BOPA Education & Training Subcommittee on 12th June 2026

BOPA Publication – Cancer pharmacists and consultant credentialing in Great Britain: an analysis of influencing factors and the impact of a dedicated support initiative 

Cancer pharmacists and consultant credentialing in Great Britain: an analysis of influencing factors and the impact of a dedicated support initiative  The study explored factors influencing cancer pharmacists’ progression through…

Read article